Developmental transcription factor EN1-a novel biomarker in human salivary gland adenoid cystic carcinoma

Cancer

Volumn 118, Issue 5, 2012, Pages 1288-1292

  Bell, Diana ^a   Bell, Achim ^b   Roberts, Dianna ^a   Weber, Randal S ^a   El Naggar, Adel K ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

adenoid cystic carcinoma; cellular localization; engrailed homeobox 1; methylation

Indexed keywords

HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EN1; TRANSCRIPTION FACTOR ENGRAILED HOMEOBOX 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; DISTANT METASTASIS; DNA METHYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TRANSCRIPTION INITIATION SITE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOID CYSTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84857363287     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26412     Document Type: Article

References (6)

1. Fordice J, Kershaw C, El-Naggar A, Goepfert H,. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999; 125: 149-152. (Pubitemid 29085262)
2. Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE,. Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg. 2004; 33: 25-31. (Pubitemid 38035489)
3. Bell A, Bell D, Weber RS, El-Naggar AK,. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer. 2011; 117: 2898-2909.
4. Mayor R, Casadome L, Azuara D, et al. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a noninvasive biomarker of disease. Br J Cancer. 2009; 100: 1534-1539.
5. Devaney J, Stirzaker C, Qu W, et al. Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers. Cancer Epidemiol Biomarkers Prev. 2011; 20: 148-159.
6. Wu X, Rauch TA, Zhong X, et al. CpG island hypermethylation in human astrocytomas. Cancer Res. 2010; 70: 2718-2727.